Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06351904
What this trial is testing

RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Ractigen Therapeutics. 72
Not applicableActive Not RecruitingNCT07511517
What this trial is testing

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell, Bladder
Oslo University Hospital 500
Not applicableStudy completedNCT00772018
What this trial is testing

Quality of Life and Symptom Management in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
David Latini 28
Not applicableUnknownNCT05146635
What this trial is testing

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Who this might be right for
Bladder Cancer
Mansoura University 110
Testing effectiveness (Phase 2)Ended earlyNCT04047693
What this trial is testing

Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder CancerUrothelial CarcinomaNeoadjuvant Chemotherapy
Pusan National University Yangsan Hospital 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808216
What this trial is testing

Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT

Who this might be right for
Non Muscle Invasive Bladder Cancer
Tianjin First Central Hospital 54
Early research (Phase 1)Study completedNCT01458847
What this trial is testing

Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
BioCis Pharma Ltd 12
Testing effectiveness (Phase 2)Study completedNCT00192049
What this trial is testing

Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
Eli Lilly and Company 90
Early research (Phase 1)WithdrawnNCT02863913
What this trial is testing

PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer

Who this might be right for
Invasive Bladder Cancer Stage IV
Peking University
Not applicableLooking for participantsNCT07225127
What this trial is testing

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Who this might be right for
Bladder CancerRecurrent Bladder CancerNon-muscle Invasive Bladder Cancer (NMIBC)
University of Washington 408
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279597
What this trial is testing

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
Tongji Hospital 45
Not applicableStudy completedNCT03091764
What this trial is testing

Evaluation of a Patient-Reported Symptom Index for NMIBC

Who this might be right for
Superficial Bladder Cancer
University of Sydney 498
Early research (Phase 1)Study completedNCT03171493
What this trial is testing

Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy

Who this might be right for
Urothelial Carcinoma
Vyriad, Inc. 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06187506
What this trial is testing

Disitamab Vedotin Combined With BCG Therapy in HER2-expressing High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder CancerHER-2 Protein Overexpression
Fudan University 20
Testing effectiveness (Phase 2)UnknownNCT04813107
What this trial is testing

Evaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Testing effectiveness (Phase 2)Study completedNCT02736266
What this trial is testing

Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma

Who this might be right for
Urothelial Bladder Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 174
Large-scale testing (Phase 3)Looking for participantsNCT07480356
What this trial is testing

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon-Muscle Invasive Bladder CarcinomaNon-muscle Invasive Bladder Cancer With Carcinoma in Situ
Protara Therapeutics 284
Testing effectiveness (Phase 2)Active Not RecruitingNCT06133517
What this trial is testing

PeRioperative Immunotherapy Combined With Sacituzumab Govitecan in Muscle Invasive blAdder Cancer

Who this might be right for
Urothelial Bladder Carcinoma
Fundación para el Progreso de la Oncología en Cantabria 70
Not applicableStudy completedNCT06768346
What this trial is testing

Hyperthermic Intra-Vesical Chemotherapy

Who this might be right for
Bladder Cancer
Queen Mary University of London 259
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06623162
What this trial is testing

Sasanlimab As Maintenance Treatment Based on Clinical Response to Neoadjuvant Treatment in Molecularly Categorized Muscle Invasive Bladder Cancer Patients

Who this might be right for
MibcMuscle Invasive Bladder Cancer
Fundación de investigación HM 70
Next Page